Clinical Trials Directory

Trials / Completed

CompletedNCT02348762

Energetics and Function in Older Humans

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Baylor College of Medicine · Academic / Other
Sex
All
Age
21 Years – 80 Years
Healthy volunteers
Accepted

Summary

The investigators have previously reported that older patients with HIV are deficient in glutathione (GSH) due to decreased availability of cysteine and glycine, and that oral supplementation with cysteine (as n-acetylcysteine) and glycine for 2-weeks corrects their own levels, and improves concentrations of red-cell GSH. The investigators also found that when GSH deficient, subjects had impaired mitochondrial energetics and this improved with an increase in intracellular GSH concentrations. The current proposal will investigate if cysteine and glycine supplementation for a duration of 24 weeks will result in changes in : (a) GSH levels; (b) body composition/anthropometry; (c) strength and function; (d) quality of life; (e) mitochondrial energetics; (f) biochemistry (including dyslipidemia and oxidative stress); (g) protein and glucose metabolism; (h) cognition and memory. 3 months after completing supplementation, measurement of GSH concentrations, strength, function, mitochondrial energetics and neurocognitive tests will be done to determine the effects of washout.

Detailed description

Data not available at present

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTCysteine (as n-acetylcysteine) and GlycineOlder subjects will be studied before and after receiving cysteine and glycine

Timeline

Start date
2014-11-01
Primary completion
2018-11-01
Completion
2021-03-01
First posted
2015-01-28
Last updated
2022-02-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02348762. Inclusion in this directory is not an endorsement.